Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

28.19 +0.47 (+1.70%)
Streaming Delayed Price Updated: 1:00 PM EDT, Jul 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Viking Therapeutics, Inc. - Common Stock

< Previous 1 2
...
11 12 13 14 15 16 17 18 19
...
24 25 Next >
Merger Mania: 3 Potential Takeover Targets to Watch for Lucrative Buyouts
With interest rates poised to fall, acquisitions will become more numerous. Here are three potential takeover targets. 
Via InvestorPlace
$1000 Invested In This Stock 5 Years Ago Would Be Worth $6,900 Today
Via Benzinga
Tuesday Talk: April Is The Cruelest Month?
At least that is what the poet T.S. Eliot wrote in the opening line of his well-known poem, 
Via Talk Markets
Could Viking Therapeutics Stock Be a Millionaire Maker?
There is a plausible path for this biotech stock to make some investors millionaires. 
Via The Motley Fool
Russell 2000 Index Best And Worst Performing Stocks Of 2024
The Russell 2000 index continued to underperform the Dow Jones and Nasdaq 100 indices in the first quarter of 2024. 
Via Talk Markets
Topics Stocks
Looking Into Viking Therapeutics's Recent Short Interest
Via Benzinga
Viking Therapeutics: Buy, Sell, or Hold?
It has a promising candidate and plenty of cash in hand. 
Via The Motley Fool
The 3 Best Biotech Stocks to Buy in April 2024
Biotech is one of the hottest sectors on the market, creating big opportunities for some of the best biotech stocks to buy in April. 
Via InvestorPlace
Viking Therapeutics Stock Has 72% Upside, According to 1 Wall Street Analyst
The company's experimental new weight-management drug looks great so far. 
Via The Motley Fool
2 Top Biotech Buyout Candidates
Investors who are adventurous, have a high-risk tolerance, and are home run hitters may opt for biotech stocks. Investors in this group may want to hone in on stocks that have the potential to be... 
Via Talk Markets
Prediction: Pfizer Won't Acquire Viking Therapeutics. Here's Why.
Viking Therapeutics may be the next company to enter the red-hot weight loss space. 
Via The Motley Fool
5 Top Stocks to Buy in April
Whether you're looking for high-powered growth or stable passive income, this basket of top stocks has it all. 
Via The Motley Fool
The 3 Best Russell 2000 Stocks to Buy in Q2 2024
Find out about the three best small-cap stocks in the best Russell 2000 to buy this upcoming quarter for significant returns. 
Via InvestorPlace
Is It Too Late to Buy Viking Therapeutics Stock?
Shares of Viking Therapeutics have skyrocketed more than 350% this year. 
Via The Motley Fool
Better Buy: Viking Therapeutics vs. Madrigal Pharmaceuticals
Both stocks are pretty risky, but one of them more so than the other. 
Via The Motley Fool
Why Viking Therapeutics Stock Was Rocketing Higher This Week
Good news from the lab and subsequent price target lifts by analysts put some zip into the company's shares. 
Via The Motley Fool
Stock Market Rally Shows Breadth As Leaders Take A Breath: Weekly Review
The stock market rally showed breadth, with small caps leading the way to a 24-month high. Growth leaders like Nvidia took a break. 
Via Investor's Business Daily
7 Stocks That Will Drive the Weight Loss Drugs Market
The booming weight loss drug market presents both lucrative potential and significant risks for investors seeking to capitalize on the global obesity crisis. 
Via MarketBeat
5 Things You Need to Know If You Buy Viking Therapeutics Stock Today
This high-flying biotech stock has captured investors' attention for all the right reasons. 
Via The Motley Fool
3 Biotech Stocks to Buy on the Dip: March 2024
Some of the best opportunities can be found in dips in some of the top biotech stocks to buy. In fact, here are three. 
Via InvestorPlace
Stocks Inch Higher, Tesla Rebounds, Bitcoin Holds Below $70,000: What's Driving Markets Tuesday?
Wall Street is set to break a two-day losing streak on Tuesday, as major indices trended positively during midday trading in New York. The S&P 500 saw a modest uptick of 0.3% for the day, with the Dow... 
Via Benzinga
Topics Stocks
DNUT Stock Soars 29% as McDonald’s Deal Supercharges Krispy Kreme
Krispy Kreme stock is rising higher on Tuesday with heavy trading of DNUT shares alongside a new collaboration agreement with McDonald’s. 
Via InvestorPlace
Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected fourth-quarter loss. Westport Fuel Systems posted a quarter loss of 81... 
Via Benzinga
Why Viking Therapeutics Stock Is Skyrocketing Today
The high-flying biotech company delivered more good news about a weight loss drug candidate. 
Via The Motley Fool
MSTR Stock Alert: MicroStrategy Releases New AI Bot
MicroStrategy stock is up on Tuesday as investors in MSTR shares react to news of a new AI bot released by the data analytics company. 
Via InvestorPlace
Topics Artificial Intelligence
Why Is Viking Therapeutics (VKTX) Stock Up 24% Today?
Viking Therapeutics stock is rising higher on Tuesday as investors in VNKTX shares react to positive Phase 1 clinical trial results. 
Via InvestorPlace
Viking Therapeutics' Investigational Oral Obesity Drug Shows Reduced Weight In Small Study
Explore Viking Therapeutics' Phase 1 MAD trial results for oral VK2735, a promising treatment for metabolic disorders like obesity. Dose-dependent reductions in body weight, encouraging... 
Via Benzinga
Viking Surges After Weight-Loss Pill Tops Expectations In Just 28 Days
People lost more weight than the company expected over a 28-day study. 
Via Investor's Business Daily
Best Obesity Drug Stock: Eli Lilly, Novo Nordisk, or Viking Therapeutics?
All three of these high-flying stocks could have more room to run. 
Via The Motley Fool
2 Soaring Growth Stocks That Could Climb Another 47% to 73%, According to Wall Street
Find out why investment banks up and down Wall Street have big expectations for these stocks. 
Via The Motley Fool
< Previous 1 2
...
11 12 13 14 15 16 17 18 19
...
24 25 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.